Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
R. Scott Greer currently holds 303,574 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, R. Scott Greer has been a net seller of NKTR stock. They have purchased $649.0K and sold $4.4M worth of shares.
R. Scott Greer's most recent insider trade was on Sep 16, 2022, when they sold 10,200 shares at $0.00 per share.
R. Scott Greer serves as Executive at NEKTAR THERAPEUTICS (NKTR). They have executed 59 insider transactions totaling $5.1M over their tenure at the company.
R. Scott Greer holds the position of Executive at NEKTAR THERAPEUTICS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
R. Scott Greer has shown a selling trading pattern, with $649.0K in total purchases and $4.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by R. Scott Greer was on Apr 6, 2018, when they sold $2.8M worth of NKTR shares. This transaction involved 30,000 shares at $92.22 per share.
R. Scott Greer currently owns 303,574 shares of NEKTAR THERAPEUTICS (NKTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of R. Scott Greer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. R. Scott Greer has 59 Form 4 filings on record as an insider at NEKTAR THERAPEUTICS.
Set alerts for R. Scott Greer and 40,000+ other insiders.